Artificial intelligence (AI) and "protein language" models can speed the design of monoclonal antibodies that prevent or reduce the severity of potentially life-threatening viral infections, according ...

Researchers at Texas Biologics at The University of Texas at Austin, working with scientists internationally, have made an important discovery that could improve treatment of human cytomegalovirus ...

G-protein coupled receptors (GPCRs) are the largest protein family encoded by the human genome and represent approximately one-third of all drug targets. However, most GPCR-targeting drugs are small ...

Antiverse, a techbio company designing antibodies for challenging targets, today announced it has added £3.5 M ($4.6 M) to its seed funding. The investment will facilitate the Company’s growth, ...